About
Upstream Bio
UPB.US
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.
Profile
- Company Name
- Upstream Bio, Inc.
- Market
- NasdaqGS
- Founded
- Industry
- --
- Fiscal Year End
- December 31
- Website
- upstreambio.com